RNA Splicing and Cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• RNA splicing is crucial for cellular functions like proliferation, survival, and differentiation.
• Aberrant RNA splicing is linked to human cancer development and progression.
• Cancer cells manipulate RNA splicing machinery and RNA-binding proteins (RBPs) to promote tumorigenesis.

Purpose of the Study:

• To review the mechanisms by which cancer cells exploit RNA splicing.
• To discuss the role of splicing machinery mutations and RBPs in cancer.
• To explore tumor-specific splicing alterations and their potential as immunotherapeutic targets.

Main Methods:

• Review of existing literature on RNA splicing in cancer.
• Analysis of genomic studies identifying splicing machinery mutations.
• Examination of next-generation RNA sequencing data for tumor-specific isoforms and neoantigens.

Main Results:

• Cancer cells utilize altered RNA splicing to enhance proliferation and survival.
• Mutations in splicing factors and dysregulated RBPs contribute to tumorigenesis.
• Tumor-specific RNA isoforms, including neoantigens, are identified as potential therapeutic targets.

Conclusions:

• RNA splicing is a critical regulatory pathway frequently dysregulated in cancer.
• Targeting cancer-specific splicing vulnerabilities offers a promising therapeutic strategy.
• Splicing-based therapies, including those targeting neoantigens, are emerging as a new frontier in cancer treatment.